Navigation Links
Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing
Date:5/15/2009

NEW YORK and ATLANTA, May 15 /PRNewswire/ -- Paul Capital Healthcare today announced that New York-based partner, John Leone, will participate in a panel on non-traditional forms of financing at the 2009 BIO International Convention. Designed to familiarize participants with how to evaluate non-dilutive financing options that can meet the needs of companies at diverse stages of development, the panel, "Non-dilutive and Other Non-traditional Forms of Financing," is scheduled for 2:00-3:30 pm ET, Wednesday, May 20th. The panel, presented as part of the Biotechnology Industry Organization International Convention, will be held at the Georgia World Congress Center in Atlanta.

Relevant at a time when IPOs are hard to execute and equity valuations uncertain, this panel will explore various models for obtaining capital for product development other than through equity finance. Mr. Leone will provide an overview and case studies of royalty and structured revenue financing transactions, as well as discuss how these financing strategies are critical for biotechnology companies in the months ahead.

"In the current financial environment, obtaining capital from traditional equity and debt markets is exceedingly difficult for small- and mid-size biotechnology companies," said John Leone, partner at Paul Capital Healthcare. "The total value of biotechnology financing transactions in 2008 was down 50% compared with 2007, and data from the first quarter of 2009 suggest that the environment will remain challenging over the near term. At the same time, increasing development costs coupled with favorable healthcare market dynamics continue to fuel the funding needs of biotechnology companies. Fortunately, there are a variety of alternative financing strategies available to companies across all stages of development, and this panel will provide insight into viable and available methods for accessing capital from investors who are actually doing deals in today's market. Both royalty monetization and revenue interest financing transactions, which are non-dilutive and can be tailored to meet the needs of individual companies, will be discussed."

About Paul Capital Healthcare and Paul Capital Partners

Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.6 billion in equity capital commitments and debt facilities under management. Combined, the Paul Capital Healthcare funds have invested more than $965 million in the pharmaceutical, biotechnology, and medical device sectors. These investments are focused on commercial stage companies and products, and consist of investments in the form of royalties, revenue interests, debt and equity. Additional information on Paul Capital Healthcare can be found at www.paulcapitalhealthcare.com. Paul Capital Partners manages nearly $6.6 billion in equity capital commitments for its three investment platforms, which include Paul Capital Healthcare, Private Equity Secondaries and Top Tier Fund-of-Funds. The firm has offices in New York, San Francisco, Paris, London, Hong Kong, and Sao Paolo.

    Contact Information:
    Paul Capital Healthcare
    John Leone, Partner
    Tel: (646) 264-1144
    Email: jleone@paulcap.com

    Lazar Partners
    Stephanie Seiler
    Tel: (206) 713-0124
    Email: sseiler@lazarpartners.com
    Susan Rood
    Tel: (212) 843-0210
    Email: srood@lazarpartners.com


'/>"/>
SOURCE Paul Capital Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the Retina Group ... New York was founded by James M. Maisel, MD and has been providing tertiary medical ... always followed a legacy of surpassing expectations amongst her peers. Growing up in a ...
(Date:12/5/2016)... (PRWEB) , ... December 05, ... ... professional calibrations is an excellent way to ensure moisture measurements are consistently ... time-consuming and impractical. , Now, METTLER TOLEDO offers a solution: ...
(Date:12/5/2016)... ... 05, 2016 , ... A newly released study has found ... and accuracy of placing precordial electrodes with little cognitive effort and a high ... years, studies have shown that single electrode misplacement is one of the single ...
(Date:12/4/2016)... California (PRWEB) , ... December 03, 2016 , ... ... lower thirds, 4 transitions and many more tools allowing FCPX editors to create ... of Pixel Film Studios. , Perfect Harmony contains a beautifully designed 3D ...
(Date:12/4/2016)... Dallas, TX (PRWEB) , ... December 03, 2016 ... ... of the “Fastest growing Entrepreneurial Company in the Dallas area” Tuesday evening at ... the Omni Dallas Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016 Sanovas, Inc., a life science ... launch of its wholly owned subsidiary, Intubation Science, Inc., and ...   Logo - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal ...
(Date:12/5/2016)... , Dec. 5, 2016  Recently Zymo ... methylation age predictor, known as Horvath,s Clock. Based ... a sample analysis service to academic and biopharma ... any human sample, other than sperm. The ... accurately estimate biological age versus chronological age following ...
(Date:12/5/2016)... Dec. 5, 2016  BD (Becton, Dickinson and Company) ... technology company, will demonstrate an enhanced technology platform designed ... including the company,s leading Pyxis™ and Alaris™ systems, at ... 2016 Midyear Meeting being held in ... While national data show that approximately 68 percent of ...
Breaking Medicine Technology: